(Q40174892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Cristobal Belda Iniesta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Marcin Skrzypski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

Miguel Ángel García-Cabezas

7 January 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Juan Carlos Lacal

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Ana Ramírez de Molina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Miquel Tarón

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Victor Ramírez de Molina

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Paloma Cejas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

David Gallego-Ortega

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Javier de Castro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Enrique Casado

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jose Javier Sánchez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Manuel Nistal

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Manuel González-Barón

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Rafael Rosell

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

889-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

The new World Health Organization classification of lung tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Gene-expression profiles predict survival of patients with lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

A molecular signature of metastasis in primary solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Erlotinib in lung cancer - molecular and clinical predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

A five-gene signature and clinical outcome in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Phospholipid metabolites, prognosis and proliferation in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Choline kinase inhibitors as a novel approach for antiproliferative drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Increased choline kinase activity and elevated phosphocholine levels in human colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Alterations of choline phospholipid metabolism in ovarian tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

From the bench to the bed: individualizing treatment in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021

Applications of genomics in NSCLC.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970279-6

7 January 2021